CD44v6: a target for antibody-based cancer therapy Karl-Heinz HeiderHartmut KuthanGerd Munzert Review 05 February 2004 Pages: 567 - 579
α-Tocopheryl succinate sensitizes established tumors to vaccination with nonmatured dendritic cells Lalitha V. RamanathapuramJames J. KobieEmmanuel T. Akporiaye Original Article 25 February 2004 Pages: 580 - 588
Identification of an antigenic peptide derived from the cancer-testis antigen NY-ESO-1 binding to a broad range of HLA-DR subtypes Frank NeumannClaudia WagnerMichael Pfreundschuh Original Article 23 January 2004 Pages: 589 - 599
Angiopoietin decoy secreted at tumor site impairs tumor growth and metastases by inducing local inflammation and altering neoangiogenesis Cecilia MelaniAntonella StoppacciaroMario P. Colombo Original Article 25 February 2004 Pages: 600 - 608
Enhancement of cytotoxic T-lymphocyte responses in patients with gastrointestinal malignancies following vaccination with CEA peptide–pulsed dendritic cells Kenji MatsudaTakuya TsunodaHiroki Yamaue Original Article 20 January 2004 Pages: 609 - 616
WT1 peptide vaccination combined with BCG-CWS is more efficient for tumor eradication than WT1 peptide vaccination alone Hiroko NakajimaKotomi KawasakiHaruo Sugiyama Original Article 07 February 2004 Pages: 617 - 624
T-cell-mediated lysis of B cells induced by a CD19xCD3 bispecific single-chain antibody is perforin dependent and death receptor independent Michael GruenKurt BommertRalf C. Bargou Original Article 06 February 2004 Pages: 625 - 632
Vaccination with p53-peptide–pulsed dendritic cells, of patients with advanced breast cancer: report from a phase I study Inge Marie SvaneAnders E. PedersenMogens H. Claesson Original Article 25 February 2004 Pages: 633 - 641
Phase I/II trial of immunogenicity of a human papillomavirus (HPV) type 16 E7 protein–based vaccine in women with oncogenic HPV-positive cervical intraepithelial neoplasia Sophie HallezPhilippe SimonNathalie Jacobs Original Article 17 February 2004 Pages: 642 - 650
Pilot study of treatment of biochemotherapy-refractory stage IV melanoma patients with autologous dendritic cells pulsed with a heterologous melanoma cell line lysate R. VilellaD. BenítezT. Castel Original Article 16 March 2004 Pages: 651 - 658
